Journal of Cardiovascular Surgery vol:45 issue:4 pages:307-19
Endoluminal grafting, introduced now 13 years ago, has been greeted enthusiastically as an alternative treatment for infrarenal abdominal aortic aneurysms (AAAs). It is estimated that last year, over 30,000 implants were performed in Europe and the US. In this review, we want to touch on the actual results of the most commonly used devices. Comparison of device-specific outcomes remains difficult however since there are few comparative and certainly no randomized studies, which is explained by the fact that the indication to treatment and selection of the device depends largely on patient related and anatomical criteria, as well as on commitment to clinical trials.